desvenlafaxine

Generic: desvenlafaxine

Labeler: actavis pharma, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name desvenlafaxine
Generic Name desvenlafaxine
Labeler actavis pharma, inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

desvenlafaxine succinate 25 mg/1

Manufacturer
Actavis Pharma, Inc.

Identifiers & Regulatory

Product NDC 0591-4060
Product ID 0591-4060_9ae096b1-2fff-4410-b1c5-799171a05d54
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA204065
Listing Expiration 2026-12-31
Marketing Start 2017-03-01

Pharmacologic Class

Classes
cytochrome p450 2d6 inhibitors [moa] norepinephrine uptake inhibitors [moa] serotonin uptake inhibitors [moa] serotonin and norepinephrine reuptake inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 05914060
Hyphenated Format 0591-4060

Supplemental Identifiers

RxCUI
1607617 1874553 1874559
UNII
ZB22ENF0XR

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name desvenlafaxine (source: ndc)
Generic Name desvenlafaxine (source: ndc)
Application Number ANDA204065 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-4060-30)
source: ndc

Packages (1)

0591-4060-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-4060-30)

Ingredients (1)

desvenlafaxine succinate (25 mg/1)

Linked Drug Pages (1)

Desvenlafaxine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "9ae096b1-2fff-4410-b1c5-799171a05d54", "openfda": {"unii": ["ZB22ENF0XR"], "rxcui": ["1607617", "1874553", "1874559"], "spl_set_id": ["617476f9-62d7-40ef-a1b1-c349d4ad706f"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-4060-30)", "package_ndc": "0591-4060-30", "marketing_start_date": "20170301"}], "brand_name": "Desvenlafaxine", "product_id": "0591-4060_9ae096b1-2fff-4410-b1c5-799171a05d54", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "0591-4060", "generic_name": "Desvenlafaxine", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Desvenlafaxine", "active_ingredients": [{"name": "DESVENLAFAXINE SUCCINATE", "strength": "25 mg/1"}], "application_number": "ANDA204065", "marketing_category": "ANDA", "marketing_start_date": "20170301", "listing_expiration_date": "20261231"}